EMAIL US AT HOPE@rummlerhope.org
CALL US NOW (952)943-3937
DONATE NOW

ADAD looking to pursue three federal grants to address the opiate epidemic

MNDHS_banner

Minnesota is continuing to experience an unprecedented rise in the use of prescription opioids. The problems associated with the increase of opioid use are statewide and include increased prevalence of addiction, pre-natal exposure to opioids, overdose and death.  In order to stem the tide, the Department of Human Services is looking into pursuing three Substance Abuse and Mental Health Services Administration (SAMHSA) grants to address the opiate epidemic.  We have provided a brief summary of these grants below and additional information is included in the SAMHSA Opioid Related Grants Document.

If Minnesota were to be selected for all three awards and then subsequently receive ongoing funding for each of the grant periods, the total amount of funding would be $9,708,080 towards addressing the opiate epidemic in Minnesota.

SAMHSA Grants that ADAD is looking into pursuing:

   1. Strategic Prevention Framework for Prescription Drugs 

The grant is designed to raise awareness about the dangers of sharing medications, work with pharmaceutical and medical communities on the risks of overprescribing to young adults. The grant will be utilized to raise community awareness by bringing prescription drug abuse prevention activities and education to schools, communities, parents, prescribers and their patients.

For more information please contact Nick Puente at 651-431-2485 or nick.puente@state.mn.us

   2. Targeted Capacity Expansion: Medication Assisted Treatment

The grant is designed to expand/enhance access to medication-assisted treatment (MAT) services for persons with opioid use disorder seeking or receiving MAT with an experienced organization, providing these services in the geographical area for a minimum of two years, that can offer an array of services with evidence based treatments integrated with primary care. A diversion mitigation plan is required, as well as a screening requirement for MAT appropriateness.  If selected, we would be seeking to implement the Medication Assisted Recovery Model.

SAMHSA’s desired outcomes include:

  • an increase in the number of admissions for MAT
  • an increase in the number of clients receiving integrated care/treatment
  • a decrease in illicit opioid drug use at 6-month follow-up
  • a decrease in the use of prescription opioids in a non-prescribed manner at 6-month follow-up.

DHS expected outcomes:

  • Expand the number of individuals on medication assisted treatment in an integrated care setting
  • Provide prescribers with additional case management resources
  • Training of subscribers
  • Development of diversion protocols
  • Provide a network of support to prescribers treating MAT clients
  • Provide evidence based individual treatment an integrated multi-disciplinary setting
  • Net result – increase in providers interested, due to support, training and protocols available to them. 

For more information please contact Tara Holt at 651-431-2473 or tara.holt@state.mn.us 

   3. Prevent Prescription Drug/Opioid Overdose-Related Deaths

The grant is designed to reduce the number of prescription drug/opioid overdose-related deaths and adverse events among individuals 18 years and older by training first responders and other key community sectors on the prevention of prescription drug/opioid overdose-related deaths and implementing secondary preventions strategies, including the purchase and distribution of naloxone to first responders.

For more information please contact Tara Holt at 651-431-2473 or tara.holt@state.mn.us

Rummler Editor

VIEW ALL POSTS

NEWSLETTER SIGN-UP

Stay up to date with the Steve Rummler HOPE Network.